Search Results - "Kumar, Deepali"

Immune dysregulation through longitudinal lymphocyte trajectories and their clinical determinants in hospitalized COVID-19 patients.

Authors: Cidade, José Pedro Taccone, Fabio Silvio Reyes, Luis Felipe et al.

Source: Intensive Care Medicine Experimental. 2/6/2026, Vol. 14 Issue 1, p1-14. 14p.

Author response to Maribavir: Double edged sword.

Authors: Blumberg, Emily A. Witzke, Oliver Harber, Mark et al.

Source: Journal of Heart & Lung Transplantation. Jun2025, Vol. 44 Issue 6, p1009-1010. 2p.

Impact of machine perfusion on transplant infectious diseases: New challenges and opportunities.

Authors: Purssell, Andrew Kumar, Deepali

Source: Transplant Infectious Disease. Nov2024 Supplement 1, Vol. 26, p1-8. 8p.

Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole.

Authors: Hall, Victoria G Tang, Kenny Kumar, Deepali et al.

Source: Open Forum Infectious Diseases. Mar2023, Vol. 10 Issue 3, p1-4. 4p.

Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS‐CoV‐2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4⁺ T‐Cell Activity.

Authors: Ferreira, Victor H. Keith, Brandon Mavandadnejad, Faranak et al.

Source: Transplant Infectious Disease. Jul2025, Vol. 27 Issue 4, p1-9. 9p.

This result is not displayed to guests.
Login for full access.

Cellular immunity to CMV: Advancing to the next level.

Authors: Kumar, Deepali¹ deepali.kumar@ualberta.ca

Source: Pediatric Transplantation. Sep2012, Vol. 16 Issue 6, p539-541. 3p.

SARS‐CoV‐2 mRNA vaccine: Sometimes life needs a boost.

Authors: Lo, Carson Ka‐Lok Kumar, Deepali

Source: Transplant Infectious Disease. Oct2023, Vol. 25 Issue 5, p1-2. 2p.

Microarray integrated spatial transcriptomics (MIST) for affordable and robust digital pathology.

Authors: Juwayria Shrivastava, Priyansh Yadav, Kaustar et al.

Source: NPJ Systems Biology & Applications. 11/30/2024, Vol. 10 Issue 1, p1-10. 10p.

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.

Authors: Ariza-Heredia, Ella J Winston, Drew J Rowley, Scott D et al.

Source: Open Forum Infectious Diseases. Aug2023, Vol. 10 Issue 8, p1-9. 9p.

Impact of immunosuppression on the immune response to SARS‐CoV‐2 infection: A mechanistic study.

Authors: Hall, Victoria G. Ferreira, Victor Kumar, Deepali et al.

Source: Transplant Infectious Disease. Dec2021, Vol. 23 Issue 6, p1-8. 8p.

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.

Authors: Kabbani, Dima Yotis, Demitra M Ferreira, Victor H et al.

Source: Open Forum Infectious Diseases. May2023, Vol. 10 Issue 5, p1-8. 8p.

High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis.

Authors: Salas, Maria Queralt Prem, Shruti Remberger, Mats et al.

Source: Leukemia & Lymphoma. Dec2020, Vol. 61 Issue 13, p3198-3208. 11p.

Characterization and predictive functional profiles on metagenomic 16S rRNA data of liver transplant recipients: A longitudinal study.

Authors: Sivaraj, Saranya Copeland, Julia K. Malik, Anshu et al.

Source: Clinical Transplantation. Feb2022, Vol. 36 Issue 2, p1-11. 11p.

Transplant center support for infectious diseases.

Authors: Schaenman, Joanna M. Kumar, Deepali Kotton, Camille N. et al.

Source: Transplant Infectious Disease. Oct2017, Vol. 19 Issue 5, pn/a-N.PAG. 7p.

The economic impact of increased length of stay associated with surgical site infections in liver transplantation on Canadian healthcare costs.

Authors: Natori, Yoichiro Vu, James Chow, Edwin et al.

Source: Clinical Transplantation. Jan2021, Vol. 35 Issue 1, p1-8. 8p.

Cytological diagnosis of solitary fibrous tumour of the lacrimal sac: Role of immunocytochemistry for STAT6.

Authors: Samaddar, Arpan Kakkar, Aanchal Sakthivel, Pirabu et al.

Source: Cytopathology. Jan2021, Vol. 32 Issue 1, p115-119. 5p.

Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.

Authors: Kumar, Deepali Patil, Nikhil Husain, Shahid et al.

Source: Clinical Transplantation. Jul2017, Vol. 31 Issue 7, pn/a-N.PAG. 8p.

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design.

Authors: Nickerson, Peter W. Böhmig, Georg A. Chadban, Steve et al.

Source: Trials. 12/22/2022, Vol. 23 Issue 1, p1-12. 12p. 1 Diagram, 4 Charts.

Clinical predictors of progression and clearance of low‐level CMV DNAemia in solid organ transplant recipients.

Authors: Natori, Yoichiro Alghamdi, Ali Husain, Shahid et al.

Source: Transplant Infectious Disease. Feb2020, Vol. 22 Issue 1, p1-6. 6p.